Latest News & Features
Asia
Takeda will sell a number of its off-patent drugs, used for treatment of diabetes, hypertension and peptic ulcers, to Teva Takeda Yakuhin for ¥28.5 billion. 17 April 2017
Americas
The US International Trade Commission has launched an investigation into intravascular administration sets, based on a complaint filed by medical device companies Curlin Medicals, Moog and Zevex. 14 April 2017
Americas
Brazil’s President Michel Temer has revealed measures aimed at improving the IP system in the country. 13 April 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a ruling of the Patent Trial and Appeal Board that a patent belonging to Novartis and Mitsubishi Pharma is obvious. 13 April 2017
Big Pharma
The UK government has revealed plans to provide £29 million ($36 million) of funding to the Roslin Institute, part of the University of Edinburgh. 12 April 2017
Americas
The 2017 “Drugs to Watch” report predicts that eight new drugs will enter the market this year and each achieve $1 billion in annual sales by 2021. 12 April 2017
Americas
Shire Viropharma has filed a motion to dismiss a complaint by the Federal Trade Commission, following competition allegations made against the pharmaceutical company. 11 April 2017
Americas
Novartis and Roxane Laboratories have entered into a settlement agreement following a patent dispute between the parties over a cancer treatment. 11 April 2017
Americas
A California-based CEO has pleaded guilty to trafficking counterfeit veterinary labels and packaging. 11 April 2017
Americas
Law firm Lewis Roca Rothgerber Christie has hired Elie Gendloff as of counsel in the firm’s IP practice group in Los Angeles. 10 April 2017